5-Amino-1MQ
A small-molecule NNMT inhibitor studied primarily in preclinical metabolic and adipose-tissue models.
FEMETRIC · 21+ ONLYFEMETRIC is a research and educational platform intended only for adults age 21 and older.
Acceptance is stored on this device and requested again after approximately 30 days.Search peptides, goals, protocols and references
FEMETRIC PEPTIDE INDEX
Search, filter and compare public records that meet the current Femetric completion standard.
A small-molecule NNMT inhibitor studied primarily in preclinical metabolic and adipose-tissue models.
A copper-binding tripeptide studied in ex vivo human hair follicles and cultured dermal papilla cells.
Modified hGH fragment (176-191) studied for lipolysis without significant IGF-1 elevation.
Synthetic 15-amino-acid gastric peptide researched for tissue repair, gut protection, and anti-inflammatory effects.
Combined local + systemic repair stack for accelerated soft-tissue recovery.
Long-acting amylin analog for appetite regulation and weight management (often studied with semaglutide as CagriSema).
Fixed dual combination of long-acting amylin analog + GLP-1 agonist for enhanced weight loss.
Classic synergistic GH secretagogue stack that produces natural-like GH pulses.
Long-acting GHRH analog that provides sustained GH and IGF-1 elevation for several days.
Delta sleep-inducing peptide for sleep architecture and stress modulation.
Synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched for pineal regulation, telomere support, and longevity signaling.
Naturally occurring copper-binding tripeptide for skin, collagen, and regenerative support.
Convenience regenerative blend of GHK-Cu, BPC-157, and TB-500.
Master intracellular antioxidant (often supported by NAC).
A mitochondrial-derived peptide studied in cellular stress, metabolism and age-associated disease models.
Long-acting IGF-1 analog researched for muscle growth and recovery.
Selective growth hormone secretagogue (GHRP) with minimal effect on cortisol or prolactin.
Neuropeptide that stimulates GnRH release → LH/FSH for reproductive axis support.
GLOW blend plus KPV for added anti-inflammatory coverage.
α-MSH C-terminal tripeptide fragment with potent anti-inflammatory effects, especially in the gut.
An approved daily GLP-1 receptor agonist studied for type 2 diabetes, weight management and cardiovascular outcomes.
A GLP-1 and glucagon receptor dual agonist studied in obesity and type 2 diabetes, with development and regulatory status varying by region.
Selective MC1R agonist for tanning and photoprotection (more selective than MT-2).
Non-selective melanocortin agonist for rapid tanning with additional systemic effects.
Mitochondrial-derived peptide that activates AMPK and supports metabolic flexibility, insulin sensitivity, and exercise capacity.
Essential coenzyme for cellular energy production, DNA repair, and sirtuin activity that declines with age.
An investigational GLP-1 and glucagon receptor dual agonist studied for obesity and metabolic liver disease.
Melanocortin receptor agonist (MC3R/MC4R) used for sexual desire and arousal.
GLP-1 / GIP / Glucagon triple agonist for substantial weight loss and metabolic improvement.
Synthetic tuftsin analog with anxiolytic and nootropic effects.
Long-acting selective GLP-1 receptor agonist for weight loss and glycemic control.
Synthetic ACTH(4-10) analog for cognitive enhancement and neuroprotection.
Short-acting GHRH analog that amplifies the body’s natural growth-hormone pulses.
Mitochondria-targeted peptide that stabilizes cardiolipin and improves electron transport chain function.
An investigational GLP-1 and glucagon receptor dual agonist in clinical development for obesity and metabolic liver disease.
Synthetic fragment of Thymosin Beta-4 that promotes cell migration and systemic tissue repair.
Synthetic GHRH analog that stimulates endogenous GH release for visceral fat reduction.
Immune-modulating peptide used for immune support and as an adjuvant in certain conditions.
Dual GIP / GLP-1 receptor agonist for superior weight loss and glycemic control.